 | Black Diamond Therapeutics, Inc | |||
| NMS : BDTX || Location: United States | ||||
$5.01-0.01 (-0.2%) |
0.36 M | 4.97 - 5.27 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 2.044 M |
| March 15, 2024 | 1.813 M |
| Feb. 29, 2024 | 1.779 M |
| Feb. 15, 2024 | 1.885 M |
| Jan. 31, 2024 | 2.399 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.48 | -0.34 | 28.47% |
| 09/30/2023 | -0.50 | -0.45 | 9.31% |
| 06/30/2023 | -0.55 | -0.52 | 4.85% |
| 03/31/2023 | -0.62 | -0.57 | 8.02% |
| 12/31/2022 | -0.64 | -0.59 | 7.84% |
BDTX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 51.718M | Shares Float | 35.919M |
| Short Float | 2.044M | Market Cap | 259.62M |
| Institution ownership | 93.57% | Insider ownership | 2.605% |
| Earnings Date | 05/08/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -1.88 | Forward EPS | -1.79 |